港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

医药外包概念

1,656.921

-15.995-0.96%

涨家数：2

跌家数：6

平家数：- -

市盈率：- -

高：1,689.707

开：1,673.364

低：1,646.606

收：1,672.916

数据加载中...

《沪深》长假期在即A股三大指数半日表现牛皮药明康德绩后升逾半成

阿斯达克财经

异动直击 | 药明康德拉升逾6%，一季度归母净利同比增近九成，维持全年双位数增长指引

港股异动 | 泰格医药(03347)绩后跌超3% 一季度归母净利同比减少近三成机构指其毛利率水平仍有提升空间

瑞银：升药明康德目标价至82.5港元评级“买入”

维亚生物盘中异动急速上涨5.52%报1.530港元

药明康德Q1业绩亮眼促CRO概念股集体走强，凯莱英涨近7%

《大行》大摩指药明康德(02359.HK)首季业绩胜预期基本面仍强

阿斯达克财经

药明康德净利暴增89%！政策红利能否催生恒生医疗ETF主升浪？

恒生生物科技ETF涨1.57%，药明康德涨5.58%

恒指涨幅扩大至1%，恒生科技指数涨2%，阿里健康涨超9%，药明康德涨超7%

每日经济新闻

药明康德AH股齐涨，Q1净利同比大增89%

港股异动药明康德高开逾5% 一季度归母净利同比增近九成维持全年双位数增长指引

药明康德(02359)出现大手买入9.67万股，成交价$62.0，涉资599.54万

阿斯达克财经

港股创新药板块盘初走高，泰凌医药(01011.HK)涨近7%，石药集团(01093.HK)涨超4%，百济神州(06160

全球创新药投融资环境有所复苏，港股生物技术板块集体大涨，药明康德早盘涨近7%

药明康德上涨6.44%，报61.95元/股

港股异动 | 石药集团(01093)涨超3% SYH2068注射液(双链小干扰RNA药物)获临床试验批准

石药集团涨超3% SYH2068注射液(双链小干扰RNA药物)获临床试验批准

Q1业绩公布！药明康德重回两位数增长

每日经济新闻

港股开盘｜恒指涨0.46%重上22000，蔚来、药明康德涨超5%

读创客户端

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BK1576/news?page=3"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1576","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1576\",,,,,undefined,":{"symbol":"BK1576","market":"HK","secType":"PLATE","nameCN":"医药外包概念","latestPrice":1656.921,"timestamp":1746000495720,"preClose":1672.9159,"halted":0,"volume":46989588,"delay":0,"changeRate":-0.009561,"floatShares":0,"shares":0,"eps":0,"marketStatus":"劳动节休市","change":-15.994873,"latestTime":"04-30 16:00:00","open":1673.3644,"high":1689.7068,"low":1646.6055,"amount":1196093850,"amplitude":0.025764,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1746149400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1745976600000,1745985600000],[1745989200000,1746000000000]],"pbRate":1.989191,"peRate":9.524219,"turnoverRate":0.003721,"increases":2,"decrements":6,"flats":0,"marketCap":350848075776,"floatMarketCap":154609044736},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1576\",,,,,undefined,":{"symbol":"BK1576","high":1689.7068,"amplitude":0.025764,"preClose":1672.9159,"low":1646.6055,"pbRate":"1.989191","latestPrice":1656.921,"volume":46989588,"delay":0,"open":1673.3644,"prevYearClose":1395.7731,"prevWeekClose":1649.561,"prevMonthClose":1656.921,"prevQuarterClose":1941.338,"fiveDayClose":1645.051,"twentyDayClose":1942.366,"sixtyDayClose":1438.36,"secType":"PLATE","market":"HK","turnoverRate":0.003721,"peRate":9.524219,"marketCap":350848075776,"floatMarketCap":154609044736,"timestamp":1746000495720,"nameCN":"医药外包概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1576\",,,,undefined,":{"bkCode":"BK1576","up":2,"down":6,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1576\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2531724552","title":"《沪深》长假期在即A股三大指数半日表现牛皮 药明康德绩后升逾半成","url":"https://stock-news.laohu8.com/highlight/detail?id=2531724552","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531724552?lang=zh_cn&edition=fundamental","pubTime":"2025-04-29 11:41","pubTimestamp":1745898060,"startTime":"0","endTime":"0","summary":"人民银行今日公开市场开展3,405亿元人民币(下同)7天期逆回购操作，操作利率持平于1.5%。今日有2,205亿元逆回购到期，单日净投放1,200亿元。人民币兑美元中间价报7.2029，上调14点。五一长假期临近，A股三大指数今早低开后表现牛皮。沪指半日跌不足1点或0.03%，收报3,287点，成交额2,689亿元。相关内容内地商业银行二季度不良率降至1.67% 上半年银行业利润增速放缓药明康德首季净利润按年增长89.06%，股价高开高走升5.2%。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20241101162005879_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20241101162005879_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1436639/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU2488822045.USD","LU0052750758.USD","LU2125910500.SGD","399300","LU2495084118.USD","LU0708995583.HKD","LU2045819591.USD","02359","LU0320764599.SGD","LU1997244956.HKD","LU2242644610.SGD","603259","LU1046422090.SGD","159982","LU1997245177.USD","BK1141","LU1997245094.SGD","BK1583","BK0216","LU0456842615.SGD","BK1576"],"gpt_icon":0},{"id":"2531617245","title":"异动直击 | 药明康德拉升逾6%，一季度归母净利同比增近九成，维持全年双位数增长指引","url":"https://stock-news.laohu8.com/highlight/detail?id=2531617245","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531617245?lang=zh_cn&edition=fundamental","pubTime":"2025-04-29 11:20","pubTimestamp":1745896807,"startTime":"0","endTime":"0","summary":"$药明康德 $高开拉升逾6%，报61.7港元，成交额7154.97万港元。消息面上， $药明康德 $ 公布2025年第一季度业绩，营业收入约96.55亿元，同比增长20.96%；归属于上市公司股东的净利润约36.72亿元，同比增长89.06%。截至2025年3月末，公司持续经营业务在手订单人民币523.3亿元，同比增长47.1%。药明康德董事长兼首席执行官李革表示，公司目前维持年初制定的全年业绩指引，预计2025年持续经营业务收入将实现10-15%的双位数增长，同时non-IFRS有望进一步提升。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042911202794e6d0f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042911202794e6d0f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0708995583.HKD","LU0320764599.SGD","02359","LU1046422090.SGD","BK1141","BK1576","BK1583","LU0052750758.USD","LU2045819591.USD","LU2242644610.SGD","LU2125910500.SGD"],"gpt_icon":0},{"id":"2531248950","title":"港股异动 | 泰格医药(03347)绩后跌超3% 一季度归母净利同比减少近三成 机构指其毛利率水平仍有提升空间","url":"https://stock-news.laohu8.com/highlight/detail?id=2531248950","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531248950?lang=zh_cn&edition=fundamental","pubTime":"2025-04-29 11:14","pubTimestamp":1745896478,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，泰格医药绩后跌超3%，截至发稿，跌2.45%，报25.95港元，成交6050.58万港元。消息面上，4月28日，泰格医药发布公告，于2025年第一季度，该集团取得营业收入15.64亿元，同比减少5.79%;归属于上市公司股东的净利润1.65亿元，同比减少29.61%;基本每股收益0.19元。此外，公司SMO业务较佳的订单支撑和效率优化下，毛利率水平仍有提升空间，实验室服务伴随着产能利用率爬坡，有望逐渐提升。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1287130.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","LU1820825898.SGD","300347","BK1583","BK0028","03347","LU1146622755.USD","BK0174","BK0216","BK1576","BK0077"],"gpt_icon":0},{"id":"2531217498","title":"瑞银：升药明康德目标价至82.5港元 评级“买入”","url":"https://stock-news.laohu8.com/highlight/detail?id=2531217498","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531217498?lang=zh_cn&edition=fundamental","pubTime":"2025-04-29 10:48","pubTimestamp":1745894891,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["02359","159201","603259","LU0456842615.SGD","LU2242644610.SGD","LU2495084118.USD","LU0052750758.USD","LU1997245177.USD","BK1576","LU1997244956.HKD","LU0708995583.HKD","BK1141","BK1583","LU1046422090.SGD","LU2045819591.USD","LU0320764599.SGD","LU2125910500.SGD","BK0216","LU1997245094.SGD","LU2488822045.USD"],"gpt_icon":0},{"id":"2531217766","title":"维亚生物盘中异动 急速上涨5.52%报1.530港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531217766","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531217766?lang=zh_cn&edition=fundamental","pubTime":"2025-04-29 10:42","pubTimestamp":1745894577,"startTime":"0","endTime":"0","summary":"2025年04月29日早盘10时42分，维亚生物股票出现波动，股价大幅拉升5.52%。截至发稿，该股报1.530港元/股，成交量43.2万股，换手率0.02%，振幅5.52%。资金方面，该股资金流入52.4805万港元，流出4.01万港元。维亚生物股票所在的生物技术行业中，整体涨幅为2.22%。其相关个股中，中国抗体-B、药明康德、加科思-B涨幅较大，振幅较大的相关个股有中国抗体-B、荣昌生物、药明巨诺-B，振幅分别为28.89%、12.08%、11.69%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042910425794e6c587&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042910425794e6c587&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","01873","BK1141"],"gpt_icon":0},{"id":"2531217793","title":"药明康德Q1业绩亮眼促CRO概念股集体走强，凯莱英涨近7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531217793","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531217793?lang=zh_cn&edition=fundamental","pubTime":"2025-04-29 10:36","pubTimestamp":1745894160,"startTime":"0","endTime":"0","summary":"药明康德2025年第一季度业绩亮眼，营业收入达96.55亿元，同比增长20.96%，净利润36.72亿元，同比大幅增长89.06%。受此利好消息影响，港股市场CRO板块集体走强，其中凯莱英涨近7%，药明康德涨近6%，维亚生物涨超3%，康龙化成和昭衍新药涨超2%。这一强劲表现不仅提振了投资者信心，也反映了市场对CRO行业前景的乐观预期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042910382097496244&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042910382097496244&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06821","LU2125910500.SGD","603259","LU0708995583.HKD","BK1141","02359","LU0320764599.SGD","BK1191","LU1046422090.SGD","LU2242644610.SGD","BK1583","BK1576","LU2045819591.USD","LU0052750758.USD"],"gpt_icon":0},{"id":"2531121066","title":"《大行》大摩指药明康德(02359.HK)首季业绩胜预期 基本面仍强","url":"https://stock-news.laohu8.com/highlight/detail?id=2531121066","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531121066?lang=zh_cn&edition=fundamental","pubTime":"2025-04-29 10:36","pubTimestamp":1745894160,"startTime":"0","endTime":"0","summary":"摩根士丹利发表研究报告指，药明康德首季收入及非通用会计准则经调整纯利分别录得96.5亿元人民币(下同)及26.8亿元，胜过该行预期。另外，公司持续经营业务积压订单按年扩张47%至523.3亿元，按首季的速度计，约相当于5至6个季度。该行亦提到作为内地的合同开发及生产组织公司，药明康德的基本面依然强劲，即使面临新冠疫情的高基数及地缘政治带来压力下。该行予其H股目标价85港元，评级“增持”。沽空资料截至 2025-04-28 16:25。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20181129150541971_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20181129150541971_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1436614/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU2242644610.SGD","603259","BK1576","02359","BK0216","LU1997244956.HKD","BK1141","LU0708995583.HKD","LU1997245094.SGD","LU2488822045.USD","LU1997245177.USD","BK1583","LU0320764599.SGD","LU1046422090.SGD","LU2495084118.USD","LU0456842615.SGD","LU2045819591.USD","LU0052750758.USD","LU2125910500.SGD"],"gpt_icon":0},{"id":"2531217795","title":"药明康德净利暴增89%！政策红利能否催生恒生医疗ETF主升浪？","url":"https://stock-news.laohu8.com/highlight/detail?id=2531217795","media":"银柿财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531217795?lang=zh_cn&edition=fundamental","pubTime":"2025-04-29 10:34","pubTimestamp":1745894061,"startTime":"0","endTime":"0","summary":"消息面上，药明康德AH股齐涨，A股一度涨超4%至60.54元，H股一度涨超7%至62.4港元。药明康德在报告中表示，营收及归母净利润实现同比增长，主要得益于在保持营业收入增长的同时，不断优化生产工艺和经营效率，以及临床后期和商业化项目增长带来的产能效率提升，提升了整体盈利能力。分业务看，药明康德化学业务同比增幅最大，达到32.87%，其次是生物学业务同比增长8.25%。相关ETF方面，恒生医疗ETF高开高走，盘中大涨超2%，成交额近7亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429103431a46b5701&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429103431a46b5701&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2045819591.USD","BK1583","LU2242644610.SGD","02359","LU0052750758.USD","LU0320764599.SGD","LU1046422090.SGD","LU2125910500.SGD","BK1576","BK1141","LU0708995583.HKD","603259"],"gpt_icon":0},{"id":"2531177962","title":"恒生生物科技ETF涨1.57%，药明康德涨5.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531177962","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531177962?lang=zh_cn&edition=fundamental","pubTime":"2025-04-29 10:29","pubTimestamp":1745893754,"startTime":"0","endTime":"0","summary":"4月29日，沪深两市震荡回暖。截至10点5分，恒生生物科技ETF(159615.SZ)涨1.57%，药明康德涨5.58%。申万宏源指出，随着创新药审批提速，医保谈判及带量采购政策倾斜本土创新药企，政策红利持续释放。基本面上，人口老龄化与消费升级驱动医疗需求扩容，本土药企研发管线进入收获期，国际化进程提速，创新药出海打开海外市场增量空间。资金面上，南向资金持续加仓港股，流动性支撑显著。板块估值经历深度回调后处于历史低位，安全边际充足，板块配置性价比突出。建议关注恒生生物科技ETF(159615.SZ)，把握行业创新升级与估值修复的双重机遇。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042910334794e6c300&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042910334794e6c300&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2045819591.USD","BK1583","LU2242644610.SGD","02359","LU0052750758.USD","LU0320764599.SGD","LU1046422090.SGD","LU2125910500.SGD","BK1576","BK1141","LU0708995583.HKD"],"gpt_icon":0},{"id":"2531217139","title":"恒指涨幅扩大至1%，恒生科技指数涨2%，阿里健康涨超9%，药明康德涨超7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531217139","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531217139?lang=zh_cn&edition=fundamental","pubTime":"2025-04-29 10:18","pubTimestamp":1745893136,"startTime":"0","endTime":"0","summary":"每经AI快讯，4月29日，恒指涨幅扩大至1%，恒生科技指数涨2%。医疗保健股涨幅居前，阿里健康涨超9%，药明康德涨超7%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://stock.eastmoney.com/a/202504293392518081.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.eastmoney.com/a/202504293392518081.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1502","LU2242644610.SGD","BK1615","BK1515","BK1501","BK1576","BK1142","BK1589","02359","BK1189","BK1141","LU0708995583.HKD","BK1571","HSTECH","BK1584","BK1247","BK1583","MCHmain","02833","00241","BK1610","LU0320764599.SGD","LU1046422090.SGD","BK1617","513600","LU2125910500.SGD","YANG","HHImain","LU2045819591.USD","HSI","LU0052750758.USD","BK1591","BK4614"],"gpt_icon":0},{"id":"2531211925","title":"药明康德AH股齐涨，Q1净利同比大增89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531211925","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531211925?lang=zh_cn&edition=fundamental","pubTime":"2025-04-29 10:02","pubTimestamp":1745892158,"startTime":"0","endTime":"0","summary":"药明康德AH股齐涨，A股一度涨超4%至60.54元，H股一度涨超7%至62.4港元。药明康德在报告中表示，营收及归母净利润实现同比增长，主要得益于在保持营业收入增长的同时，不断优化生产工艺和经营效率，以及临床后期和商业化项目增长带来的产能效率提升，提升了整体盈利能力。分业务看，药明康德化学业务同比增幅最大，达到32.87%，其次是生物学业务同比增长8.25%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042910091994e6ba74&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042910091994e6ba74&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2125910500.SGD","02359","LU0708995583.HKD","LU2242644610.SGD","LU0052750758.USD","BK1576","LU2045819591.USD","BK1583","LU0320764599.SGD","LU1046422090.SGD","BK1141"],"gpt_icon":0},{"id":"2531211912","title":"港股异动 药明康德高开逾5% 一季度归母净利同比增近九成 维持全年双位数增长指引","url":"https://stock-news.laohu8.com/highlight/detail?id=2531211912","media":"金融界","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531211912?lang=zh_cn&edition=fundamental","pubTime":"2025-04-29 09:53","pubTimestamp":1745891630,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，药明康德(02359)高开逾5%，截至发稿，涨5.15%，报61.2港元，成交额1438.2万港元。消息面上，药明康德公布2025年第一季度业绩，营业收入约96.55亿元，同比增长20.96%；归属于上市公司股东的净利润约36.72亿元，同比增长89.06%。截至2025年3月末，公司持续经营业务在手订单人民币523.3亿元，同比增长47.1%。药明康德董事长兼首席执行官李革表示，公司目前维持年初制定的全年业绩指引，预计2025年持续经营业务收入将实现10-15%的双位数增长，同时non-IFRS（经调整后的净利润）有望进一步提升。”本文源自：智通财经网","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042909561494e6b583&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042909561494e6b583&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2125910500.SGD","BK1141","LU0708995583.HKD","BK1583","LU0320764599.SGD","LU2045819591.USD","LU0052750758.USD","02359","LU2242644610.SGD","BK1576","LU1046422090.SGD"],"gpt_icon":0},{"id":"2531521182","title":"药明康德(02359)出现大手买入9.67万股，成交价$62.0，涉资599.54万","url":"https://stock-news.laohu8.com/highlight/detail?id=2531521182","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531521182?lang=zh_cn&edition=fundamental","pubTime":"2025-04-29 09:50","pubTimestamp":1745891400,"startTime":"0","endTime":"0","summary":"[大手成交]药明康德(02359)在上午09:50出现大手买入，成交量为9.67万，成交价为港币$62.0，涉资599.54万。至目前为止，股价升6.443%，今日最高价为$62.4，而最低价为$60.55，总成交量为441.539万股，总成交金额港币$2.714亿。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145552499_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145552499_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2504293045/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU1997244956.HKD","LU1997245094.SGD","BK1141","BK1583","LU1997245177.USD","LU2242644610.SGD","02359","LU2495084118.USD","LU2125910500.SGD","BK0216","LU2045819591.USD","LU0320764599.SGD","BK1576","LU0456842615.SGD","LU0708995583.HKD","LU1046422090.SGD","LU0052750758.USD","603259","LU2488822045.USD"],"gpt_icon":0},{"id":"2531821605","title":"港股创新药板块盘初走高，泰凌医药(01011.HK)涨近7%，石药集团(01093.HK)涨超4%，百济神州(06160","url":"https://stock-news.laohu8.com/highlight/detail?id=2531821605","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531821605?lang=zh_cn&edition=fundamental","pubTime":"2025-04-29 09:49","pubTimestamp":1745891393,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["LU1226287529.USD","LU0588546209.SGD","ONC","LU0417516738.SGD","01093","HSTECH","603127","LU0456846285.SGD","BK1610","BK1161","LU0856984785.SGD","BK1576","LU0819121731.USD","LU1226287792.SGD","LU0140636845.USD","LU1008478684.HKD","06127","159992","LU0823426308.USD","LU1960683339.HKD","LU1880383366.USD","IE00B031HY20.USD","BK4614","BK1583","06160","LU1688375341.USD","LU1720050803.USD","LU0880133367.SGD","688235","LU1226288253.USD","LU1152091754.HKD","IE0008369823.USD","06978","01011","02269","LU0708995583.HKD","LU0051755006.USD","IE00B5MMRT66.SGD","BK1141","LU0359201612.USD","YANG","LU2328871848.SGD","IE00BZ08YR35.GBP","LU0348825331.USD","07226","BK1588","SG9999004220.SGD","LU0823426480.USD","HSCEI","LU0516423091.SGD"],"gpt_icon":0},{"id":"2531219315","title":"全球创新药投融资环境有所复苏，港股生物技术板块集体大涨，药明康德早盘涨近7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531219315","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531219315?lang=zh_cn&edition=fundamental","pubTime":"2025-04-29 09:48","pubTimestamp":1745891280,"startTime":"0","endTime":"0","summary":"　　4月29日消息，港股生物技术板块多股大涨，截至发稿，药明康德、科伦博泰生物涨近6%，创胜集团、来凯医药、乐普生物涨超5%，云顶新耀、中国抗体、康方生物涨超4%。　　消息面上，国投证券发布研报称，全球创新药投融资环境有所复苏，多肽、ADC等细分领域创新研发蓬勃兴起，加速推动CXO行业景气度上行，研发生产外包需求有望逐步改善。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/2025-04-29/doc-ineuuwaf5333570.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2242644610.SGD","BK1576","LU1997244956.HKD","BK0216","LU1997245177.USD","159992","LU2488822045.USD","BK1583","LU0708995583.HKD","LU2495084118.USD","603259","HSCEI","BK1574","02359","HSTECH","BK1141","LU0320764599.SGD","LU1046422090.SGD","LU1997245094.SGD","LU0456842615.SGD","YANG","LU0052750758.USD","LU2045819591.USD","BK1161","06978","BK4614","LU2125910500.SGD"],"gpt_icon":1},{"id":"2531167312","title":"药明康德上涨6.44%，报61.95元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2531167312","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531167312?lang=zh_cn&edition=fundamental","pubTime":"2025-04-29 09:42","pubTimestamp":1745890934,"startTime":"0","endTime":"0","summary":"4月29日，药明康德(02359)盘中上涨6.44%，截至09:34，报61.95元/股，成交1.33亿元。药明康德提供一体化的新药研发和生产服务，覆盖化学药、生物学研究、临床前测试及临床试验等领域，服务全球超过6,000家合作伙伴。公司通过CRDMO业务模式降低研发门槛，提升研发效率，致力于为全球患者带来创新治疗方案。截至2025年一季报，药明康德营业总收入96.55亿元、净利润35.36亿元。4月28日，2025财年一季报归属股东应占溢利35.36亿人民币，同比增长82.07%，基本每股收益1.24人民币。本文源自：金融界作者：行情君","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042909433497494dce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042909433497494dce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0052750758.USD","LU0708995583.HKD","BK1141","LU2125910500.SGD","02359","BK1583","LU1046422090.SGD","LU2045819591.USD","BK1576","LU2242644610.SGD","LU0320764599.SGD"],"gpt_icon":0},{"id":"2531545216","title":"港股异动 | 石药集团(01093)涨超3% SYH2068注射液(双链小干扰RNA药物)获临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2531545216","media":"智通财经","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531545216?lang=zh_cn&edition=fundamental","pubTime":"2025-04-29 09:42","pubTimestamp":1745890923,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，石药集团涨超3%，截至发稿，涨3.48%，报6.25港元，成交额1.77亿港元。消息面上，近日，石药集团发布公告，本集团自主研发的化学1类新药SYH2068注射液(该产品)已获得中华人民共和国国家药品监督管理局批准，可以在中国开展临床试验。临床前研究显示，该产品在药物活性和药效持续性方面优于同类型si RNA产品，展现出药物作用效果持久、安全性好、患者依从性高等差异化优势，具有较高的临床开发价值。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1287089.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0501845795.SGD","IE00B031HY20.USD","IE00BZ08YS42.EUR","BK1191","01093","LU1226287529.USD","BK1515","LU0140636845.USD","LU0880133367.SGD","LU1152091168.USD","LU1226288253.USD","LU0067412154.USD","LU1226287875.USD","IE00B543WZ88.USD","LU0326950275.SGD","BK1521","LU1993786604.SGD","BK1141","LU1226288170.HKD","BK4505","BK4585","LU1008478684.HKD","RNA","IE0008369823.USD","LU1152091754.HKD","LU1960683339.HKD","BK1583","BK4588","03347","IE0008368742.USD","IE00B5MMRT66.SGD","BK4139","IE00BZ08YR35.GBP","LU0072913022.USD","LU1951186391.HKD","LU1226287792.SGD","SG9999004220.SGD","IE00BZ08YT58.USD","LU1807302812.USD","BK1576"],"gpt_icon":0},{"id":"2531211983","title":"石药集团涨超3% SYH2068注射液(双链小干扰RNA药物)获临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2531211983","media":"动脉网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531211983?lang=zh_cn&edition=fundamental","pubTime":"2025-04-29 09:42","pubTimestamp":1745890920,"startTime":"0","endTime":"0","summary":"石药集团SYH2068注射液获批临床试验，该双链小干扰RNA药物可降低脂蛋白(a)水平，预防动脉粥样硬化，临床前研究显优势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042909511794e6b3f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042909511794e6b3f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1152091754.HKD","IE00B543WZ88.USD","LU0326950275.SGD","LU1951186391.HKD","LU1993786604.SGD","LU1226288253.USD","LU1960683339.HKD","BK1141","IE00B031HY20.USD","LU0140636845.USD","BK1515","LU1226288170.HKD","LU0880133367.SGD","LU1226287529.USD","SG9999004220.SGD","01093","BK1521","IE00BZ08YR35.GBP","LU0072913022.USD","LU1807302812.USD","IE00BZ08YT58.USD","LU1226287875.USD","LU1152091168.USD","LU1226287792.SGD","IE00B5MMRT66.SGD","IE0008369823.USD","LU0501845795.SGD","LU1008478684.HKD","BK1576","IE0008368742.USD","BK1191","LU0067412154.USD","03347","BK1583","IE00BZ08YS42.EUR"],"gpt_icon":0},{"id":"2531758216","title":"Q1业绩公布！药明康德重回两位数增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2531758216","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531758216?lang=zh_cn&edition=fundamental","pubTime":"2025-04-29 09:39","pubTimestamp":1745890755,"startTime":"0","endTime":"0","summary":"据药明康德公告，其2025年第一季度收入及利润均重回双位数增长（整体营业收入+21%，持营业务收入+23.1%，归母净利润+89.1%）。全球创新药投融持续复苏背景下，2025Q1公司持续经营业务在手订单同比增长47.1%，在手订单的高速增长，驱动核心业务经营快速改善。在关税扰动背景下，恒生医药近期表现持续强势。近期一季度报告密集发布，荣昌生物、药明康德等业绩利好频传，有望进一步提振医药热度。相关ETF：恒生医药ETF（159892）：持仓药明康德、药明生物、药明合联生物科技ETF（516500）：聚焦医药龙头，药明康德权重近12%每日经济新闻","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429094303a6cc767a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429094303a6cc767a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2045819591.USD","LU2125910500.SGD","LU0052750758.USD","BK1576","BK1141","LU1046422090.SGD","LU2242644610.SGD","LU0708995583.HKD","BK1583","02359","LU0320764599.SGD"],"gpt_icon":0},{"id":"2531211948","title":"港股开盘｜恒指涨0.46%重上22000，蔚来、药明康德涨超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531211948","media":"读创客户端","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531211948?lang=zh_cn&edition=fundamental","pubTime":"2025-04-29 09:29","pubTimestamp":1745890159,"startTime":"0","endTime":"0","summary":"观望美国与其他国家的贸易谈判进展及即将出炉的美企业绩，美股周一反复尾盘回稳。港股今早高开，恒指高开0.46%报22073点，恒生科技指数高开0.67%，国企指数高开0.42%。个股方面，蔚来涨超5%领涨恒生科技指数成分股，CEO李斌笃定今年Q4会盈利；理想汽车涨超2%，地平线机器人、舜宇、携程、阿里健康、京东涨超1%；恒指及成分股中，药明康德涨超5%，Q1净利36.72亿元，同比增89.06%；药明生物、申洲国际、中升控股、吉利汽车、蒙牛乳业、周大福涨超1%。来源：读创财经","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042909423294e6b024&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042909423294e6b024&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2242644610.SGD","BK1576","09866","MCHmain","HSI","BK1119","BK1588","BK1583","LU0708995583.HKD","513600","HSCEI","02359","HSTECH","BK1141","LU0320764599.SGD","LU1046422090.SGD","LU0052750758.USD","LU2045819591.USD","HHImain","02833","LU2125910500.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}